HRP20050468A2 - Pulverulent formulation for inhalation containing tiotropium - Google Patents
Pulverulent formulation for inhalation containing tiotropiumInfo
- Publication number
- HRP20050468A2 HRP20050468A2 HR20050468A HRP20050468A HRP20050468A2 HR P20050468 A2 HRP20050468 A2 HR P20050468A2 HR 20050468 A HR20050468 A HR 20050468A HR P20050468 A HRP20050468 A HR P20050468A HR P20050468 A2 HRP20050468 A2 HR P20050468A2
- Authority
- HR
- Croatia
- Prior art keywords
- containing tiotropium
- inhalation containing
- pulverulent formulation
- pulverulent
- formulation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0001—Details of inhalators; Constructional features thereof
- A61M15/0021—Mouthpieces therefor
- A61M15/0025—Mouthpieces therefor with caps
- A61M15/0026—Hinged caps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
- A61M15/0033—Details of the piercing or cutting means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/06—Solids
- A61M2202/064—Powder
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Anesthesiology (AREA)
- Heart & Thoracic Surgery (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Otolaryngology (AREA)
- Emergency Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Izum se odnosi na praškaste pripravke koji sadržetiotropij, na postupke za njihovu proizvodnju kaoi na njihovu upotrebu za proizvodnju lijeka za liječenje bolesti dišnih puteva, posebno za liječenje COPD-a (chronic obstructive pulmonary disease = kronična opstrukcijska bolest pluća) i astme.The invention relates to powdered compositions containing thiotropium, to processes for their production as well as to their use for the production of a medicament for the treatment of respiratory diseases, in particular for the treatment of COPD and chronic asthma.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10255387A DE10255387A1 (en) | 2002-11-28 | 2002-11-28 | New tiotropium-containing powder formulation for inhalation |
PCT/EP2003/012911 WO2004047796A2 (en) | 2002-11-28 | 2003-11-19 | Pulverulent formulation for inhalation containing tiotropium |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20050468A2 true HRP20050468A2 (en) | 2006-07-31 |
Family
ID=32308760
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR20050468A HRP20050468A2 (en) | 2002-11-28 | 2005-05-27 | Pulverulent formulation for inhalation containing tiotropium |
Country Status (34)
Country | Link |
---|---|
EP (1) | EP1567135B1 (en) |
JP (1) | JP4977321B2 (en) |
KR (1) | KR101066805B1 (en) |
CN (1) | CN100574751C (en) |
AR (1) | AR042242A1 (en) |
AT (1) | ATE401861T1 (en) |
AU (1) | AU2003294714B2 (en) |
BR (1) | BR0316343A (en) |
CA (1) | CA2507579C (en) |
CO (1) | CO5580736A2 (en) |
CY (1) | CY1108420T1 (en) |
DE (2) | DE10255387A1 (en) |
DK (1) | DK1567135T3 (en) |
EA (1) | EA011549B1 (en) |
EC (1) | ECSP055821A (en) |
ES (1) | ES2310681T3 (en) |
HK (1) | HK1085918A1 (en) |
HR (1) | HRP20050468A2 (en) |
IL (1) | IL168810A (en) |
ME (1) | MEP51608A (en) |
MX (1) | MXPA05005485A (en) |
MY (1) | MY140890A (en) |
NO (1) | NO20053090L (en) |
PE (1) | PE20040848A1 (en) |
PL (1) | PL376229A1 (en) |
PT (1) | PT1567135E (en) |
RS (1) | RS20050400A (en) |
SA (1) | SA04240467B1 (en) |
SI (1) | SI1567135T1 (en) |
TW (1) | TWI332837B (en) |
UA (1) | UA81930C2 (en) |
UY (1) | UY28096A1 (en) |
WO (1) | WO2004047796A2 (en) |
ZA (1) | ZA200502859B (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102006016904A1 (en) | 2006-04-11 | 2007-10-25 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | inhaler |
DE102008014025A1 (en) * | 2008-03-13 | 2009-09-17 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Inhaler and strainer for an inhaler |
TR200909788A2 (en) | 2009-12-25 | 2011-07-21 | Bi̇lgi̇ç Mahmut | Dry powder formulation suitable for inhalation with tiotropium |
SI2600830T1 (en) * | 2010-08-03 | 2018-05-31 | Chiesi Farmaceutici S.P.A. | Dry powder formulation comprising a phosphodiesterase inhibitor |
WO2014074797A1 (en) * | 2012-11-09 | 2014-05-15 | Civitas Therapeutics, Inc. | Ultra low density pulmonary powders |
KR101748796B1 (en) * | 2015-09-30 | 2017-06-19 | 한미약품 주식회사 | Inhalation capsule with enhanced delivery rate of active ingredients |
KR101728116B1 (en) * | 2015-11-03 | 2017-04-18 | 한미약품 주식회사 | Dry powder composition for inhalation comprising tiotropium or pharmaceutically acceptable salt thereof |
CN111514418B (en) * | 2019-06-12 | 2022-01-14 | 中南大学湘雅二医院 | Self-suction nasal powder material feeding device |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1242211A (en) * | 1967-08-08 | 1971-08-11 | Fisons Pharmaceuticals Ltd | Pharmaceutical composition |
DE4140689B4 (en) * | 1991-12-10 | 2007-11-22 | Boehringer Ingelheim Kg | Inhalable powders and process for their preparation |
DE4318455A1 (en) * | 1993-06-03 | 1994-12-08 | Boehringer Ingelheim Kg | Capsule holder |
GB9322014D0 (en) * | 1993-10-26 | 1993-12-15 | Co Ordinated Drug Dev | Improvements in and relating to carrier particles for use in dry powder inhalers |
DE4425255A1 (en) * | 1994-07-16 | 1996-01-18 | Asta Medica Ag | Formulation for inhalation application |
CZ303154B6 (en) * | 1998-11-13 | 2012-05-09 | Jagotec Ag | Dry powder formulation for inhalation containing magnesium stearate |
GB9902689D0 (en) * | 1999-02-08 | 1999-03-31 | Novartis Ag | Organic compounds |
UA75375C2 (en) * | 2000-10-12 | 2006-04-17 | Boehringer Ingelheim Pharma | Method for producing powdery preparations for inhaling |
BR0107304A (en) * | 2000-10-12 | 2002-08-13 | Boehringer Ingelheim Pharma | Inhalation powder containing tiotropium |
DE10126924A1 (en) * | 2001-06-01 | 2002-12-05 | Boehringer Ingelheim Pharma | Inhalation capsule contains powdered mixture of tiotropium and auxiliary, for treating asthma or chronic obstructive pulmonary disease, having capsule material of low moisture content to improve stability |
DE10141377A1 (en) * | 2001-08-23 | 2003-03-13 | Boehringer Ingelheim Pharma | Scattering process for the production of powder formulations |
AU2003221531B2 (en) * | 2002-04-04 | 2008-10-23 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Powder formulations suitable for inhalation |
UA80123C2 (en) * | 2002-04-09 | 2007-08-27 | Boehringer Ingelheim Pharma | Inhalation kit comprising inhalable powder of tiotropium |
-
2002
- 2002-11-28 DE DE10255387A patent/DE10255387A1/en not_active Withdrawn
-
2003
- 2003-11-19 ES ES03785648T patent/ES2310681T3/en not_active Expired - Lifetime
- 2003-11-19 DE DE50310208T patent/DE50310208D1/en not_active Expired - Lifetime
- 2003-11-19 EP EP03785648A patent/EP1567135B1/en not_active Revoked
- 2003-11-19 DK DK03785648T patent/DK1567135T3/en active
- 2003-11-19 KR KR1020057009548A patent/KR101066805B1/en active IP Right Grant
- 2003-11-19 AU AU2003294714A patent/AU2003294714B2/en not_active Expired
- 2003-11-19 SI SI200331323T patent/SI1567135T1/en unknown
- 2003-11-19 BR BR0316343-1A patent/BR0316343A/en active Pending
- 2003-11-19 PL PL03376229A patent/PL376229A1/en unknown
- 2003-11-19 WO PCT/EP2003/012911 patent/WO2004047796A2/en active IP Right Grant
- 2003-11-19 CA CA2507579A patent/CA2507579C/en not_active Expired - Fee Related
- 2003-11-19 EA EA200500864A patent/EA011549B1/en not_active IP Right Cessation
- 2003-11-19 JP JP2004554384A patent/JP4977321B2/en not_active Expired - Lifetime
- 2003-11-19 AT AT03785648T patent/ATE401861T1/en active
- 2003-11-19 ME MEP-516/08A patent/MEP51608A/en unknown
- 2003-11-19 MX MXPA05005485A patent/MXPA05005485A/en active IP Right Grant
- 2003-11-19 RS YUP-2005/0400A patent/RS20050400A/en unknown
- 2003-11-19 PT PT03785648T patent/PT1567135E/en unknown
- 2003-11-19 CN CN200380104599A patent/CN100574751C/en not_active Expired - Lifetime
- 2003-11-19 UA UAA200506224A patent/UA81930C2/en unknown
- 2003-11-26 PE PE2003001200A patent/PE20040848A1/en not_active Application Discontinuation
- 2003-11-26 TW TW092133185A patent/TWI332837B/en not_active IP Right Cessation
- 2003-11-26 UY UY28096A patent/UY28096A1/en not_active Application Discontinuation
- 2003-11-27 MY MYPI20034544A patent/MY140890A/en unknown
- 2003-11-28 AR ARP030104393A patent/AR042242A1/en active Pending
-
2004
- 2004-01-03 SA SA04240467A patent/SA04240467B1/en unknown
-
2005
- 2005-04-08 ZA ZA200502859A patent/ZA200502859B/en unknown
- 2005-05-26 IL IL168810A patent/IL168810A/en not_active IP Right Cessation
- 2005-05-26 EC EC2005005821A patent/ECSP055821A/en unknown
- 2005-05-27 HR HR20050468A patent/HRP20050468A2/en not_active Application Discontinuation
- 2005-06-23 NO NO20053090A patent/NO20053090L/en not_active Application Discontinuation
- 2005-06-27 CO CO05062904A patent/CO5580736A2/en not_active Application Discontinuation
-
2006
- 2006-05-23 HK HK06105905.7A patent/HK1085918A1/en not_active IP Right Cessation
-
2008
- 2008-10-16 CY CY20081101149T patent/CY1108420T1/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20050570A2 (en) | Powdered medicament for inhalation comprising a tiotropium salt and salmetrol xinafoate | |
MEP40108A (en) | Novel tiotropium-containing inhalation powder | |
HRP20050468A2 (en) | Pulverulent formulation for inhalation containing tiotropium | |
MEP30108A (en) | Formoterol superfine formulation | |
MY155912A (en) | New inhalable powder containing tiotropium | |
HRP20040933B1 (en) | Inhalation kit comprisung inhalable powder of tiotropium | |
MXPA02011311A (en) | Novel composition. | |
ME00349B (en) | Novel crystalline anhydride with anticholinergic effect | |
MY145166A (en) | Novel tiotropium salts, process for the preparation and pharmaceutical compositions thereof | |
EA201401354A1 (en) | NEW DOSED FORM AND PREPARATION CONTAINING ABEDTEROL | |
EA201201391A1 (en) | INHALER | |
NO20073909L (en) | Nebulized formulation | |
EA201201393A1 (en) | INHALER, DEVELOPED FOR DELIVERY OF MEDICINES AS DRY POWDER | |
MEP51308A (en) | Method for producing tiotropium salts, tiotropium salts and pharmaceutical formulations, containing the same | |
WO2007046113A3 (en) | Novel pharmaceutical composition comprising alkaloid and process thereof | |
DK1494648T3 (en) | Powder for inhalation | |
CY1113392T1 (en) | NEW CRYSTAL FORMS OF TIOTROPIO BRUMIDE | |
BRPI0415685A (en) | tiotropium salts, processes for their production as well as drug formulations containing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A1OB | Publication of a patent application | ||
AIPI | Request for the grant of a patent on the basis of a substantive examination of a patent application | ||
ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20141107 Year of fee payment: 12 |
|
ODBI | Application refused |